USPTO trademark

LEMBAYLI

RegisteredUSPTOWord markClass 5

"LEMBAYLI" is a word mark owned by Antibe Therapeutics Inc., filed at the USPTO on December 1, 2021. It is registered and covers class 5 (Pharmaceuticals).

View Antibe Therapeutics Inc. portfolio Get this data via the API

Data current as of November 11, 2025Official USPTO record

As filed with the USPTO

Status: Registered; Since November 11, 2025
Filed: December 1, 2021
Registered: November 11, 2025
Priority date: June 9, 2021; Claimed from Canada
Application no.: 97150915
Registration no.: 8017101
Office: USPTO; United States Patent and Trademark Office
Mark type: Word mark; 1 class

Ownership

Who owns LEMBAYLI

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Antibe Therapeutics Inc.

Toronto, Ontario, Canada

2 trademarks in the portfolioView company

Representative

Frances M. Jagla

Christensen O'Connor Johnson Kindness

Goods and services

What the mark covers

The products and services LEMBAYLI is filed for, grouped by Nice class.

05Class 5 · Pharmaceuticals
Pharmaceuticals, namely, anti-inflammatories; anti-inflammatory pharmaceutical preparations; preparations for the relief of pain; pharmaceutical preparations for the relief of pain

History

What has happened so far

Steps recorded by the USPTO, newest first.

November 11, 2025Notice of registration confirmation emailed
November 11, 2025Registered-principal register
October 30, 2025Post publication amendment - entered
October 29, 2025Assigned to petition staff
September 23, 2025Teas post publication amendment received
September 23, 2025Official gazette publication confirmation e-mailed
September 23, 2025Published for opposition
September 17, 2025Notification of notice of publication e-mailed
August 23, 2025Approved for pub - principal register
July 18, 2025Teas/email correspondence entered

10 earlier steps on the official record.

FAQ

About LEMBAYLI

Who owns the trademark "LEMBAYLI"?

The USPTO trademark "LEMBAYLI" (application 97150915) is owned by Antibe Therapeutics Inc.

What is the status of "LEMBAYLI"?

Its status at the USPTO is: registered.

When was "LEMBAYLI" registered?

It was registered on November 11, 2025.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull LEMBAYLI and marks like it into your own product with one request.

GET/v1/trademarks/{id}
The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/events
Every step in the office history
GET/v1/proceedings?trademark_id={id}
Oppositions and cancellations against the mark

Get API key View docs

GET /v1/trademarks/{id}

ID=tm_019d29ed-0d94-7279-9d01-542e30f8d025
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"

Response

{
  "id": "tm_019d29ed-0d94-7279-9d01-542e30f8d025",
  "object": "trademark",
  "mark_text": "LEMBAYLI",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "US",
  "application_number": "97150915",
  "filing_date": "2021-12-01",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "Antibe Therapeutics Inc.",
      "entity_id": "ent_019eb70d-9caf-73f9-9f82-452156269e9f"
    }
  ]
}